Sidney M Morris Selected Research

Arginase

8/2017	Arginase-2 mediates renal ischemia-reperfusion injury.
11/2015	FoxO4 promotes early inflammatory response upon myocardial infarction via endothelial Arg1.
9/2015	Arginase inhibition: a new treatment for preventing progression of established diabetic nephropathy.
12/2014	Diabetic nephropathy is resistant to oral L-arginine or L-citrulline supplementation.
1/2014	The central role of arginine catabolism in T-cell dysfunction and increased susceptibility to infection after physical injury.
12/2013	Arginase inhibition mediates renal tissue protection in diabetic nephropathy by a nitric oxide synthase 3-dependent mechanism.
7/2013	Microenvironments in tuberculous granulomas are delineated by distinct populations of macrophage subsets and expression of nitric oxide synthase and arginase isoforms.
1/2012	Arginases and arginine deficiency syndromes.
1/2012	Selective endothelial overexpression of arginase II induces endothelial dysfunction and hypertension and enhances atherosclerosis in mice.
11/2011	Arginase-2 mediates diabetic renal injury.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sidney M Morris Research Topics

Disease

7	Albuminuria 01/2020 - 11/2011
7	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 11/2011
6	Inflammation (Inflammations) 11/2015 - 02/2005
5	Hemolysis 01/2012 - 07/2005
5	Sickle Cell Anemia (Hemoglobin S Disease) 03/2007 - 07/2003
4	Pulmonary Hypertension 05/2010 - 07/2003
3	Stroke (Strokes) 01/2019 - 04/2003
3	Infections 01/2014 - 06/2005
3	Atherosclerosis 01/2012 - 12/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 12/2010
2	Ischemia 08/2017 - 11/2015
2	Hypertension (High Blood Pressure) 01/2012 - 05/2010
2	Spinal Cord Injuries (Spinal Cord Injury) 01/2010 - 09/2008
2	Lung Diseases (Lung Disease) 01/2007 - 03/2006
2	Asthma (Bronchial Asthma) 03/2006 - 07/2004
1	Herpes Simplex 10/2020
1	Chronic Kidney Failure (Chronic Renal Failure) 01/2020
1	Hyperargininemia 08/2017
1	Infarction (Infarctions) 11/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2014
1	Granuloma 07/2013
1	Neoplasms (Cancer) 09/2011
1	Hyperplasia 04/2011
1	Vascular System Injuries 04/2011
1	Right Ventricular Dysfunction 05/2010
1	Thrombosis (Thrombus) 04/2010
1	Neurogenic Urinary Bladder (Bladder, Neurogenic) 09/2008
1	Reperfusion Injury 03/2007
1	Body Weight (Weight, Body) 01/2007
1	Pneumonia (Pneumonitis) 01/2007
1	Silicosis 01/2007
1	Priapism 03/2006
1	Chronic Obstructive Pulmonary Disease (COPD) 03/2006
1	Hypoxia (Hypoxemia) 02/2005
1	Wounds and Injuries (Trauma) 02/2005

Drug/Important Bio-Agent (IBA)

23	ArginaseIBA 08/2017 - 07/2003
17	Arginine (L-Arginine)FDA Link 12/2014 - 04/2003
15	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 07/2003
7	Nitric Oxide Synthase (NO Synthase)IBA 08/2017 - 04/2003
5	CytokinesIBA 01/2020 - 06/2005
4	NitrogenIBA 12/2014 - 04/2003
3	Amino Acids FDA Link 10/2020 - 07/2004
3	Thiobarbituric Acid Reactive SubstancesIBA 01/2020 - 09/2015
3	Messenger RNA (mRNA)IBA 01/2020 - 09/2008
3	NitratesIBA 09/2015 - 04/2011
3	NitritesIBA 09/2015 - 04/2011
3	Urea (Carbamide)FDA LinkGeneric 12/2014 - 11/2011
3	Proteins (Proteins, Gene)FDA Link 12/2014 - 02/2005
3	Protein Isoforms (Isoforms)IBA 07/2013 - 01/2007
2	Drinking WaterIBA 01/2019 - 12/2014
2	Streptozocin (Streptozotocin)FDA Link 10/2017 - 12/2014
2	nephrinIBA 09/2015 - 12/2014
2	CitrullineIBA 12/2014 - 07/2005
2	Fibronectins (Fibronectin)IBA 12/2014 - 12/2013
2	EnzymesIBA 07/2013 - 02/2005
2	PolyaminesIBA 03/2007 - 02/2005
2	Hemoglobins (Hemoglobin)IBA 03/2006 - 07/2005
1	Essential Amino AcidsIBA 10/2020
1	N,N-dimethylarginine (asymmetric dimethylarginine)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	HomoarginineIBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 08/2017
1	Adenosine Triphosphate (ATP)IBA 08/2017
1	Cysteine (L-Cysteine)FDA Link 08/2017
1	Forkhead Transcription Factors (Forkhead Box Proteins)IBA 11/2015
1	Captopril (Capoten)FDA LinkGeneric 09/2015
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2015
1	CreatinineIBA 12/2013
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2012
1	(2-boronoethyl)-cysteineIBA 11/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 09/2011
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2011
1	Liver X ReceptorsIBA 08/2011
1	Sodium NitriteIBA 04/2011
1	Xanthine DehydrogenaseIBA 04/2011
1	Nitrite Reductases (Nitrite Reductase)IBA 04/2011
1	Apolipoproteins E (ApoE)IBA 12/2010
1	IsoenzymesIBA 12/2010
1	CholesterolIBA 12/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2010
1	pro-brain natriuretic peptide (1-76)IBA 05/2010
1	eculizumab FDA Link 05/2010
1	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2010
1	Thrombin FDA Link 04/2010
1	daidzeinIBA 01/2010
1	Silicon Dioxide (Silica)FDA LinkGeneric 01/2007
1	A-factor (Streptomyces)IBA 01/2007
1	Biomarkers (Surrogate Marker)IBA 03/2006
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2006
1	Oxyhemoglobins (Oxyhemoglobin)IBA 03/2006
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 03/2006
1	BilirubinIBA 03/2006
1	HaptoglobinsIBA 03/2006
1	Phosphodiesterase 4 InhibitorsIBA 03/2006
1	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 03/2006
1	OrnithineIBA 07/2005
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 06/2005
1	Biological ProductsIBA 02/2005

Therapy/Procedure

3	Therapeutics 10/2017 - 07/2003
1	Intraperitoneal Injections 01/2014